Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Study details cancer risk of Takeda diabetes pill
Reuters
Friday, June 1, 2012 - 10:30am
tags:
diabetes, bladder cancer, Takeda, Actos
J&J files diabetes drug canagliflozin with FDA
Pharma Times, UK
Friday, June 1, 2012 - 10:29am
tags:
diabetes, JNJ, FDA, canagliflozin
Forest Laboratories and Nabriva Therapeutics Sign Agreement
Yahoo
Friday, June 1, 2012 - 10:28am
tags:
Forest Labs, Nabriva Therapeutics, BC-3781, M&A
Trius: Tedizolid Prospects In MRSA Lead To Initiation With A Buy
Seeking Alpha
Friday, June 1, 2012 - 10:27am
tags:
Trius Therapeutics, MRSA, tedizolid, antibiotics
Cancer Incidence May Surge 75% By 2030, Lancet Says
Bloomberg
Friday, June 1, 2012 - 10:26am
tags:
cancer
WebMD snares former Pfizer exec as CEO
Yahoo/AP
Friday, June 1, 2012 - 10:25am
tags:
Pfizer, WebMD
Pre-Clinical Data Demonstrates Promising Potential of MannKind’s IRE1α Inhibitor to Treat Multiple Myeloma
Yahoo
Thursday, May 31, 2012 - 6:26pm
tags:
MannKind, IRE1α inhibitor, MKC-3946, Multiple Myeloma
Sanofi Aims To Be Pharma’s Top R&D Organization, Zerhouni Says
Bloomberg
Thursday, May 31, 2012 - 6:17pm
tags:
R&D, Sanofi
BioMarin to Raise Funds
Yahoo/Zacks
Thursday, May 31, 2012 - 6:15pm
tags:
Biomarin, stock offering
Human Genome Sciences Takeover Defense Survives Court Test
Bloomberg
Thursday, May 31, 2012 - 6:13pm
tags:
Human Genome Sciences, GSK, M&A, hostile bid
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Thursday, May 31, 2012 - 6:11pm
tags:
Sanofi, liver cancer, GSK, AstraZeneca, Bristol-Myers Squibb
No Good News for Waiting Chelsea Investors
Motley Fool
Thursday, May 31, 2012 - 6:09pm
tags:
Chelsea Therapeutics, Northera, CH-4051, rheumatoid arthritis
The Drug Works, but Is It Worth Proceeding?
Motley Fool
Thursday, May 31, 2012 - 6:08pm
tags:
Alnylam, ALN-RSV01
Medivation Emerges With New Prostate Cancer Drug
Xconomy
Thursday, May 31, 2012 - 10:17am
tags:
Medivation, prostate cancer, MDV3100, Astellas
Teva Begins Trading on the New York Stock Exchange
Yahoo
Thursday, May 31, 2012 - 10:14am
tags:
Teva Pharmaceuticals, NYSE
Icahn nominates new directors to Forest Labs board
Yahoo/AP
Thursday, May 31, 2012 - 10:11am
tags:
Carl Icahn, Forest Labs
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thursday, May 31, 2012 - 9:38am
tags:
AstraZeneca, JNJ, Bristol-Myers Squibb, Eli Lilly, Pfizer, Sanofi, GSK
Ampio Pharmaceuticals Is On The Move
Seeking Alpha
Thursday, May 31, 2012 - 9:31am
tags:
Ampio Pharmaceuticals, Zertane
The Tale of 2 Patents
Motley Fool
Thursday, May 31, 2012 - 9:24am
tags:
patents, Amarin, AMR-101, GSK, Teva Pharmaceuticals, Par Pharmaceutical, Pronova BioPharma ASA
Merck, Pfizer Back Lawmakers Who Oppose Company Products
Bloomberg
Thursday, May 31, 2012 - 9:16am
tags:
Merck, Pfizer, contraceptives, healthcare reform

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.